ISLET CELL TRANSPLANT
OFFERS NEW LIFE FOR 52-YEAR-OLD ACTOR FROM COLORADO
Last Halloween, Steph skipped the candy corn and instead went for 400,000 islet cells, injected into a vein near his liver. On Thanksgiving, Steph got not cranberries - but another 400,000 islet (rhymes with pilot) cells.
In December, just in time for Christmas, Steph got his final dose of islet cells. And suddenly, the insulin highs and sugar lows that have made his life a living hell for 23 years are nearly gone. "Holy gotchamoley!" said Steph, 52, an actor who lives in Parker Colorado. "It means the world; it means everything to me." Steph is apparently the first person in the Rocky Mountain region to receive an islet cell transplant, an experimental procedure aimed at bringing stability to diabetics who can't regulate their blood sugars. Because the procedure is experimental, Steph worries that his insurance carrier might drop him if they knew, so he requested that his last name not be used. Some 18 million people in the United States, 6.3 percent of the population, have diabetes, according to the American Diabetes Association. The annual economic cost of diabetes is $132 billion, or one of every 10 U.S. health care dollars, says the association.
The first islet cell transplant was done
four years ago in Edmonton, Alberta Canada. A study of 36 islet cell
recipients found that 19 remained insulin independent a year after the
procedure, said Dr. James Shapiro, director of the program in Edmonton. Of
the 17 who still need insulin, seven of those have derived some benefit
and improvement in quality of life. A whole pancreas transplant is another
option, but the pancreas is a fragile organ, and typically just 10 percent
are suitable, he said. So, Steph got on the list for islet cell
transplant. "I got the call in the middle of the night on Halloween eve,"
Dr. Wiseman recalled. An organ donor had just died and his pancreas
couldn't be used, but might be suitable for harvesting islet cells. A five
person team that is on call 365 days a year sprung into action, injecting
the pancreas with a collagenase to break it down. It took them seven hours
to harvest the islet cells from the pancreas and get them into a small
sterile tube. With the help of diabetes specialist Dr. Peter Gottleib, an
interventional radiologist, and a team of nurses, DR.Wiseman prepared
Steph for the procedure. A needle poked through the skin in Steph's
abdomen and went into a vessel next to his liver. A catheter slid in, the
needle came out, and the islet cells dripped in from an IV bag. When it was over, a Band Aid protected
the BB-sized incision. The second opportunity to harvest and inject came
on Thanksgiving Day, and the third came last month. Steph will have to
take anti rejection medication the rest of his life, which will leave him
more vulnerable to infections and can cause mouth ulcers, high blood
pressure, high cholesterol and gastro- intestinal problems. But so far,
"we've seen zero side effects in Steph," Dr. Wiseman said. He was back on
the insulin pump for a couple of weeks to give the islets a rest. After
that, however, they should be ready for full action on their own. For diabetics who have good control over
their blood sugars, islet cell transplants probably aren't worth the
trade-offs, Dr. Wiseman said. Still, the waiting list for the transplant
is growing weekly, he said. "We'll never have enough cadavers to meet
demand," he said. For his part, Steph hopes he has seen the last of the
days when, once or twice a day he'd slow to a crawl and couldn't raise his
arms until he got another dose of insulin. "I'll be able to drive anywhere
and not have to worry about it now," he said. "This means everything." .